Chemical Compound
Cabotegravir sodium
CAS Registry Number
1051375-13-3
Primary Record
Cabotegravir sodium
- In stock
- 4,866 g
- Purity
- 99.5 %
- CAS
- 1051375-13-3
Compound Identifiers & Properties
- CAS
- 1051375-13-3
- PubChem CID
- 46215800
- SMILES
- C[C@H]1CO[C@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
- Canonical SMILES
- C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12.[Na+]
Names & Synonyms
- Cabotegravir sodium
- Vocabria
- Cabotegravir-sodium
- Cabotegravir (sodium)
- Vocabria (TN)
- Cabotegravir Sodium?
- Cabotegravir sodium [USAN]
- 1051375-13-3
- GSK1265744B
- RefChem:54589
- GSK-1265744B
- UNII-3L12PT535M
- 3L12PT535M
- UNII-HMH0132Z1Q
- S-265744B
- C19H16F2N3NaO5
- CHEBI:172948
- orb1908995
- CHEMBL3137330
- SCHEMBL29393452
- Cabotegravir sodium (JAN/USAN)
- CABOTEGRAVIR SODIUM [JAN]
- S 265744B
- AMY30044
- CABOTEGRAVIR SODIUM [WHO-DD]
- EBC-97034
- GSK 1265744B
- HY-15592A
- ACN-041361
- CABOTEGRAVIR SODIUM [ORANGE BOOK]
- AC-30853
- DA-51525
- CS-0007799
- D10549
- F11513
- Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
- A935003
- Q27257476
- Oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide, N-((2,4-difluorophenyl)methyl)-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, sodium salt (1:1), (3S,11aR)-
- Sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate
- sodium;(3R,6S)-12-[(2,4-difluorophenyl)methylcarbamoyl]-6-methyl-8,11-dioxo-4-oxa-1,7-diazatricyclo[7.4.0.03,7]trideca-9,12-dien-10-olate
- (3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, sodium salt
- 857-514-0
- Cabotegravir sodium|1051375-13-3|GSK1265744B|GSK-1265744B|UNII-3L12PT535M|Cabotegravir (sodium)|S-265744B|S 265744B|3L12PT535M|Vocabria|Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate|Cabotegravir sodium [USAN]|CHEMBL3137330|Cabotegravir sodium (JAN/USAN)|CHEBI:172948|AMY30044|GSK 1265744B|HY-15592A|AC-30853|Oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide, N-((2,4-difluorophenyl)methyl)-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, sodium salt (1:1), (3S,11aR)-|Sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate|CS-0007799|D10549|F11513|A935003|Q27257476|(3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, sodium s
- sodium (3S,11aR)-8-[(2,4-difluorobenzyl)carbamoyl]-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
- Sodium (3S,11aR)-8-{[(2,4-difluorophenyl)methyl]carbamoyl}-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
- Sodium(3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate